Filing Flows › Black Diamond Therapeutics (BDTX) › How it makes money
How Black Diamond Therapeutics (BDTX) makes money
Black Diamond Therapeutics (BDTX) made $70.0M of revenue in the first quarter 2025 (Q1 2025). Of every dollar of revenue, 78¢ was left as operating profit, 81¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2025 | % of revenue |
|---|---|---|
| Revenue | $70.0M | 100.0% |
| Operating profit | $54.5M | 77.9% |
| Income tax | $226K | 0.3% |
| Net earnings | $56.5M | 80.8% |
| Operating cash flow | $53.4M | 76.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2025 | $70.0M | — |
From Black Diamond Therapeutics' 10-Q filed May 12, 2025 (on EDGAR).
Questions
How does Black Diamond Therapeutics make money?
Black Diamond Therapeutics (BDTX) made $70.0M of revenue in the first quarter 2025 (Q1 2025). Of every dollar of revenue, 78¢ was left as operating profit, 81¢ was left as net earnings.
What is Black Diamond Therapeutics' profit margin?
Net earnings were $56.5M, 80.8% of revenue, in the first quarter 2025; the operating margin was 77.9%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.